Anthony Pease, Clement Lo, Arul Earnest, Velislava Kiriakova, Danny Liew, Sophia Zoungas. Diabetes Technol Ther 2020
Times Cited: 5
Times Cited: 5
Times Cited
Times Co-cited
Similarity
Diabetes Device Use in Adults With Type 1 Diabetes: Barriers to Uptake and Potential Intervention Targets.
Molly L Tanenbaum, Sarah J Hanes, Kellee M Miller, Diana Naranjo, Rachel Bensen, Korey K Hood. Diabetes Care 2017
Molly L Tanenbaum, Sarah J Hanes, Kellee M Miller, Diana Naranjo, Rachel Bensen, Korey K Hood. Diabetes Care 2017
60
Six-Month Randomized, Multicenter Trial of Closed-Loop Control in Type 1 Diabetes.
Sue A Brown, Boris P Kovatchev, Dan Raghinaru, John W Lum, Bruce A Buckingham, Yogish C Kudva, Lori M Laffel, Carol J Levy, Jordan E Pinsker, R Paul Wadwa,[...]. N Engl J Med 2019
Sue A Brown, Boris P Kovatchev, Dan Raghinaru, John W Lum, Bruce A Buckingham, Yogish C Kudva, Lori M Laffel, Carol J Levy, Jordan E Pinsker, R Paul Wadwa,[...]. N Engl J Med 2019
40
Efficacy of continuous glucose monitoring in improving glycemic control and reducing hypoglycemia: a systematic review and meta-analysis of randomized trials.
Gunjan Y Gandhi, Michelle Kovalaske, Yogish Kudva, Kristin Walsh, Mohamed B Elamin, Melody Beers, Cathy Coyle, Melissa Goalen, Mohammad Safwan Murad, Patricia J Erwin,[...]. J Diabetes Sci Technol 2011
Gunjan Y Gandhi, Michelle Kovalaske, Yogish Kudva, Kristin Walsh, Mohamed B Elamin, Melody Beers, Cathy Coyle, Melissa Goalen, Mohammad Safwan Murad, Patricia J Erwin,[...]. J Diabetes Sci Technol 2011
40
Long-term health economic benefits of sensor-augmented pump therapy vs continuous subcutaneous insulin infusion alone in type 1 diabetes: a U.K. perspective.
Stéphane Roze, Jayne Smith-Palmer, William J Valentine, Mark Cook, Manisha Jethwa, Simona de Portu, John C Pickup. J Med Econ 2016
Stéphane Roze, Jayne Smith-Palmer, William J Valentine, Mark Cook, Manisha Jethwa, Simona de Portu, John C Pickup. J Med Econ 2016
40
Severe hypoglycaemia in 1076 adult patients with type 1 diabetes: influence of risk markers and selection.
Ulrik Pedersen-Bjergaard, Stig Pramming, Simon R Heller, Tara M Wallace, Ase K Rasmussen, Hanne V Jørgensen, David R Matthews, Philip Hougaard, Birger Thorsteinsson. Diabetes Metab Res Rev 2004
Ulrik Pedersen-Bjergaard, Stig Pramming, Simon R Heller, Tara M Wallace, Ase K Rasmussen, Hanne V Jørgensen, David R Matthews, Philip Hougaard, Birger Thorsteinsson. Diabetes Metab Res Rev 2004
40
Glucose Outcomes with the In-Home Use of a Hybrid Closed-Loop Insulin Delivery System in Adolescents and Adults with Type 1 Diabetes.
Satish K Garg, Stuart A Weinzimer, William V Tamborlane, Bruce A Buckingham, Bruce W Bode, Timothy S Bailey, Ronald L Brazg, Jacob Ilany, Robert H Slover, Stacey M Anderson,[...]. Diabetes Technol Ther 2017
Satish K Garg, Stuart A Weinzimer, William V Tamborlane, Bruce A Buckingham, Bruce W Bode, Timothy S Bailey, Ronald L Brazg, Jacob Ilany, Robert H Slover, Stacey M Anderson,[...]. Diabetes Technol Ther 2017
40
A cost-effectiveness analysis of sensor-augmented insulin pump therapy and automated insulin suspension versus standard pump therapy for hypoglycemic unaware patients with type 1 diabetes.
Trang T Ly, Alan J M Brnabic, Andrew Eggleston, Athena Kolivos, Margaret E McBride, Rudolf Schrover, Timothy W Jones. Value Health 2014
Trang T Ly, Alan J M Brnabic, Andrew Eggleston, Athena Kolivos, Margaret E McBride, Rudolf Schrover, Timothy W Jones. Value Health 2014
40
Cost-Effectiveness of Sensor-Augmented Pump Therapy with Low Glucose Suspend Versus Standard Insulin Pump Therapy in Two Different Patient Populations with Type 1 Diabetes in France.
Stéphane Roze, Jayne Smith-Palmer, William Valentine, Vincent Payet, Simona de Portu, Natalie Papo, Michel Cucherat, Helene Hanaire. Diabetes Technol Ther 2016
Stéphane Roze, Jayne Smith-Palmer, William Valentine, Vincent Payet, Simona de Portu, Natalie Papo, Michel Cucherat, Helene Hanaire. Diabetes Technol Ther 2016
40
Cost-effectiveness of sensor-augmented pump therapy in two different patient populations with type 1 diabetes in Italy.
A Nicolucci, M C Rossi, D D'Ostilio, A Delbaere, S de Portu, S Roze. Nutr Metab Cardiovasc Dis 2018
A Nicolucci, M C Rossi, D D'Ostilio, A Delbaere, S de Portu, S Roze. Nutr Metab Cardiovasc Dis 2018
66
Why Expectations Will Determine the Future of Artificial Pancreas.
Laurel H Messer. Diabetes Technol Ther 2018
Laurel H Messer. Diabetes Technol Ther 2018
40
Cost-Effectiveness Analysis of the MiniMed 670G Hybrid Closed-Loop System Versus Continuous Subcutaneous Insulin Infusion for Treatment of Type 1 Diabetes.
Johan Jendle, Johannes Pöhlmann, Simona de Portu, Jayne Smith-Palmer, Stéphane Roze. Diabetes Technol Ther 2019
Johan Jendle, Johannes Pöhlmann, Simona de Portu, Jayne Smith-Palmer, Stéphane Roze. Diabetes Technol Ther 2019
40
Cost-effectiveness of sensor-augmented pump therapy versus standard insulin pump therapy in patients with type 1 diabetes in Denmark.
S Roze, S de Portu, J Smith-Palmer, A Delbaere, W Valentine, M Ridderstråle. Diabetes Res Clin Pract 2017
S Roze, S de Portu, J Smith-Palmer, A Delbaere, W Valentine, M Ridderstråle. Diabetes Res Clin Pract 2017
40
Safety of a Hybrid Closed-Loop Insulin Delivery System in Patients With Type 1 Diabetes.
Richard M Bergenstal, Satish Garg, Stuart A Weinzimer, Bruce A Buckingham, Bruce W Bode, William V Tamborlane, Francine R Kaufman. JAMA 2016
Richard M Bergenstal, Satish Garg, Stuart A Weinzimer, Bruce A Buckingham, Bruce W Bode, William V Tamborlane, Francine R Kaufman. JAMA 2016
40
Clinical effectiveness and cost-effectiveness of continuous subcutaneous insulin infusion for diabetes: systematic review and economic evaluation.
E Cummins, P Royle, A Snaith, A Greene, L Robertson, L McIntyre, N Waugh. Health Technol Assess 2010
E Cummins, P Royle, A Snaith, A Greene, L Robertson, L McIntyre, N Waugh. Health Technol Assess 2010
40
Glycaemic control in type 1 diabetes during real time continuous glucose monitoring compared with self monitoring of blood glucose: meta-analysis of randomised controlled trials using individual patient data.
John C Pickup, Suzanne C Freeman, Alex J Sutton. BMJ 2011
John C Pickup, Suzanne C Freeman, Alex J Sutton. BMJ 2011
40
Insulin pump therapy: a meta-analysis.
Jill Weissberg-Benchell, Jeanne Antisdel-Lomaglio, Roopa Seshadri. Diabetes Care 2003
Jill Weissberg-Benchell, Jeanne Antisdel-Lomaglio, Roopa Seshadri. Diabetes Care 2003
40
Glycaemic control with continuous subcutaneous insulin infusion compared with intensive insulin injections in patients with type 1 diabetes: meta-analysis of randomised controlled trials.
John Pickup, Martin Mattock, Sally Kerry. BMJ 2002
John Pickup, Martin Mattock, Sally Kerry. BMJ 2002
40
Integrated sensor-augmented pump therapy systems [the MiniMed® Paradigm™ Veo system and the Vibe™ and G4® PLATINUM CGM (continuous glucose monitoring) system] for managing blood glucose levels in type 1 diabetes: a systematic review and economic evaluation.
Rob Riemsma, Isaac Corro Ramos, Richard Birnie, Nasuh Büyükkaramikli, Nigel Armstrong, Steve Ryder, Steven Duffy, Gill Worthy, Maiwenn Al, Johan Severens,[...]. Health Technol Assess 2016
Rob Riemsma, Isaac Corro Ramos, Richard Birnie, Nasuh Büyükkaramikli, Nigel Armstrong, Steve Ryder, Steven Duffy, Gill Worthy, Maiwenn Al, Johan Severens,[...]. Health Technol Assess 2016
40
Current state of type 1 diabetes treatment in the U.S.: updated data from the T1D Exchange clinic registry.
Kellee M Miller, Nicole C Foster, Roy W Beck, Richard M Bergenstal, Stephanie N DuBose, Linda A DiMeglio, David M Maahs, William V Tamborlane. Diabetes Care 2015
Kellee M Miller, Nicole C Foster, Roy W Beck, Richard M Bergenstal, Stephanie N DuBose, Linda A DiMeglio, David M Maahs, William V Tamborlane. Diabetes Care 2015
40
Clinical efficacy and safety of abatacept in methotrexate-naive patients with early rheumatoid arthritis and poor prognostic factors.
R Westhovens, M Robles, A C Ximenes, S Nayiager, J Wollenhaupt, P Durez, J Gomez-Reino, W Grassi, B Haraoui, W Shergy,[...]. Ann Rheum Dis 2009
R Westhovens, M Robles, A C Ximenes, S Nayiager, J Wollenhaupt, P Durez, J Gomez-Reino, W Grassi, B Haraoui, W Shergy,[...]. Ann Rheum Dis 2009
20
C-peptide is the appropriate outcome measure for type 1 diabetes clinical trials to preserve beta-cell function: report of an ADA workshop, 21-22 October 2001.
Jerry P Palmer, G Alexander Fleming, Carla J Greenbaum, Kevan C Herold, Lisa D Jansa, Hubert Kolb, John M Lachin, Kenneth S Polonsky, Paolo Pozzilli, Jay S Skyler,[...]. Diabetes 2004
Jerry P Palmer, G Alexander Fleming, Carla J Greenbaum, Kevan C Herold, Lisa D Jansa, Hubert Kolb, John M Lachin, Kenneth S Polonsky, Paolo Pozzilli, Jay S Skyler,[...]. Diabetes 2004
20
Transient Epstein-Barr virus reactivation in CD3 monoclonal antibody-treated patients.
Bart Keymeulen, Sophie Candon, Samira Fafi-Kremer, Anette Ziegler, Marianne Leruez-Ville, Chantal Mathieu, Evy Vandemeulebroucke, Markus Walter, Laurent Crenier, Eric Thervet,[...]. Blood 2010
Bart Keymeulen, Sophie Candon, Samira Fafi-Kremer, Anette Ziegler, Marianne Leruez-Ville, Chantal Mathieu, Evy Vandemeulebroucke, Markus Walter, Laurent Crenier, Eric Thervet,[...]. Blood 2010
20
Changing the landscape for type 1 diabetes: the first step to prevention.
Colin M Dayan, Maria Korah, Danijela Tatovic, Brian N Bundy, Kevan C Herold. Lancet 2019
Colin M Dayan, Maria Korah, Danijela Tatovic, Brian N Bundy, Kevan C Herold. Lancet 2019
20
Porcine CTLA4-Ig prolong islet xenografts in rats by downregulating the direct pathway of T-cell activation.
Chao Zhai, Liang Yu, Haitao Zhu, Min Tian, Zhang Xiaogang, Wang Bo. Xenotransplantation 2011
Chao Zhai, Liang Yu, Haitao Zhu, Min Tian, Zhang Xiaogang, Wang Bo. Xenotransplantation 2011
20
Immunotherapy of type 1 diabetes: where are we and where should we be going?
Xunrong Luo, Kevan C Herold, Stephen D Miller. Immunity 2010
Xunrong Luo, Kevan C Herold, Stephen D Miller. Immunity 2010
20
CD28 and CTLA-4 have opposing effects on the response of T cells to stimulation.
M F Krummel, J P Allison. J Exp Med 1995
M F Krummel, J P Allison. J Exp Med 1995
20
The evolving clinical profile of abatacept (CTLA4-Ig): a novel co-stimulatory modulator for the treatment of rheumatoid arthritis.
Eric M Ruderman, Richard M Pope. Arthritis Res Ther 2005
Eric M Ruderman, Richard M Pope. Arthritis Res Ther 2005
20
Differentiation of Diabetes by Pathophysiology, Natural History, and Prognosis.
Jay S Skyler, George L Bakris, Ezio Bonifacio, Tamara Darsow, Robert H Eckel, Leif Groop, Per-Henrik Groop, Yehuda Handelsman, Richard A Insel, Chantal Mathieu,[...]. Diabetes 2017
Jay S Skyler, George L Bakris, Ezio Bonifacio, Tamara Darsow, Robert H Eckel, Leif Groop, Per-Henrik Groop, Yehuda Handelsman, Richard A Insel, Chantal Mathieu,[...]. Diabetes 2017
20
Long-term acceptance of skin and cardiac allografts after blocking CD40 and CD28 pathways.
C P Larsen, E T Elwood, D Z Alexander, S C Ritchie, R Hendrix, C Tucker-Burden, H R Cho, A Aruffo, D Hollenbaugh, P S Linsley,[...]. Nature 1996
C P Larsen, E T Elwood, D Z Alexander, S C Ritchie, R Hendrix, C Tucker-Burden, H R Cho, A Aruffo, D Hollenbaugh, P S Linsley,[...]. Nature 1996
20
Long-term safety of subcutaneous abatacept in rheumatoid arthritis: integrated analysis of clinical trial data representing more than four years of treatment.
Rieke Alten, Jeffrey Kaine, Edward Keystone, Peter Nash, Ingrid Delaet, Mark C Genovese. Arthritis Rheumatol 2014
Rieke Alten, Jeffrey Kaine, Edward Keystone, Peter Nash, Ingrid Delaet, Mark C Genovese. Arthritis Rheumatol 2014
20
A new member of the immunoglobulin superfamily--CTLA-4.
J F Brunet, F Denizot, M F Luciani, M Roux-Dosseto, M Suzan, M G Mattei, P Golstein. Nature 1987
J F Brunet, F Denizot, M F Luciani, M Roux-Dosseto, M Suzan, M G Mattei, P Golstein. Nature 1987
20
Metabolic and immunological effects of cyclosporin in recently diagnosed type 1 diabetes mellitus.
R Assan, G Feutren, M Debray-Sachs, M C Quiniou-Debrie, C Laborie, G Thomas, L Chatenoud, J F Bach. Lancet 1985
R Assan, G Feutren, M Debray-Sachs, M C Quiniou-Debrie, C Laborie, G Thomas, L Chatenoud, J F Bach. Lancet 1985
20
Costimulatory blockade in patients with rheumatoid arthritis: a pilot, dose-finding, double-blind, placebo-controlled clinical trial evaluating CTLA-4Ig and LEA29Y eighty-five days after the first infusion.
Larry W Moreland, Rieke Alten, Filip Van den Bosch, Thierry Appelboom, Marc Leon, Paul Emery, Stanley Cohen, Michael Luggen, William Shergy, Isaac Nuamah,[...]. Arthritis Rheum 2002
Larry W Moreland, Rieke Alten, Filip Van den Bosch, Thierry Appelboom, Marc Leon, Paul Emery, Stanley Cohen, Michael Luggen, William Shergy, Isaac Nuamah,[...]. Arthritis Rheum 2002
20
Factors affecting and patterns of residual insulin secretion during the first year of type 1 (insulin-dependent) diabetes mellitus in children.
E B Sochett, D Daneman, C Clarson, R M Ehrlich. Diabetologia 1987
E B Sochett, D Daneman, C Clarson, R M Ehrlich. Diabetologia 1987
20
Pharmacokinetics and pharmacodynamics of CTLA4lg (BMS-188667), a novel immunosuppressive agent, in monkeys following multiple doses.
N R Srinivas, R S Weiner, G Warner, W C Shyu, T Davidson, C G Fadrowski, L K Tay, J S Lee, D S Greene, R H Barbhaiya. J Pharm Sci 1996
N R Srinivas, R S Weiner, G Warner, W C Shyu, T Davidson, C G Fadrowski, L K Tay, J S Lee, D S Greene, R H Barbhaiya. J Pharm Sci 1996
20
2. Classification and Diagnosis of Diabetes: Standards of Medical Care in Diabetes-2018.
. Diabetes Care 2018
. Diabetes Care 2018
20
Immune Intervention and Preservation of Pancreatic Beta Cell Function in Type 1 Diabetes.
Kimber M Simmons, Peter A Gottlieb, Aaron W Michels. Curr Diab Rep 2016
Kimber M Simmons, Peter A Gottlieb, Aaron W Michels. Curr Diab Rep 2016
20
Abatacept improves whole-body insulin sensitivity in rheumatoid arthritis: an observational study.
Francesco Ursini, Emilio Russo, Marta Letizia Hribal, Daniele Mauro, Francesca Savarino, Caterina Bruno, Cesare Tripolino, Mariangela Rubino, Saverio Naty, Rosa Daniela Grembiale. Medicine (Baltimore) 2015
Francesco Ursini, Emilio Russo, Marta Letizia Hribal, Daniele Mauro, Francesca Savarino, Caterina Bruno, Cesare Tripolino, Mariangela Rubino, Saverio Naty, Rosa Daniela Grembiale. Medicine (Baltimore) 2015
20
Blockade of both B7-H4 and CTLA-4 co-signaling pathways enhances mouse islet allograft survival.
Xiaojie Wang, Jianqiang Hao, Daniel L Metzger, Alice Mui, I-Fang Lee, Noushin Akhoundsadegh, C Lieping Chen, Dawei Ou, Ziliang Ao, C Bruce Verchere,[...]. Islets 2012
Xiaojie Wang, Jianqiang Hao, Daniel L Metzger, Alice Mui, I-Fang Lee, Noushin Akhoundsadegh, C Lieping Chen, Dawei Ou, Ziliang Ao, C Bruce Verchere,[...]. Islets 2012
33
Costimulation modulation with abatacept in patients with recent-onset type 1 diabetes: follow-up 1 year after cessation of treatment.
Tihamer Orban, Brian Bundy, Dorothy J Becker, Linda A Dimeglio, Stephen E Gitelman, Robin Goland, Peter A Gottlieb, Carla J Greenbaum, Jennifer B Marks, Roshanak Monzavi,[...]. Diabetes Care 2014
Tihamer Orban, Brian Bundy, Dorothy J Becker, Linda A Dimeglio, Stephen E Gitelman, Robin Goland, Peter A Gottlieb, Carla J Greenbaum, Jennifer B Marks, Roshanak Monzavi,[...]. Diabetes Care 2014
20
Fall in C-peptide during first 2 years from diagnosis: evidence of at least two distinct phases from composite Type 1 Diabetes TrialNet data.
Carla J Greenbaum, Craig A Beam, David Boulware, Stephen E Gitelman, Peter A Gottlieb, Kevan C Herold, John M Lachin, Paula McGee, Jerry P Palmer, Mark D Pescovitz,[...]. Diabetes 2012
Carla J Greenbaum, Craig A Beam, David Boulware, Stephen E Gitelman, Peter A Gottlieb, Kevan C Herold, John M Lachin, Paula McGee, Jerry P Palmer, Mark D Pescovitz,[...]. Diabetes 2012
20
Immunogenicity, safety, and efficacy of abatacept administered subcutaneously with or without background methotrexate in patients with rheumatoid arthritis: results from a phase III, international, multicenter, parallel-arm, open-label study.
Peter Nash, Sauithree Nayiager, Mark C Genovese, Alan J Kivitz, Kurt Oelke, Charles Ludivico, William Palmer, Cristian Rodriguez, Ingrid Delaet, Ayanbola Elegbe,[...]. Arthritis Care Res (Hoboken) 2013
Peter Nash, Sauithree Nayiager, Mark C Genovese, Alan J Kivitz, Kurt Oelke, Charles Ludivico, William Palmer, Cristian Rodriguez, Ingrid Delaet, Ayanbola Elegbe,[...]. Arthritis Care Res (Hoboken) 2013
20
Low-dose otelixizumab anti-CD3 monoclonal antibody DEFEND-1 study: results of the randomized phase III study in recent-onset human type 1 diabetes.
Ronnie Aronson, Peter A Gottlieb, Jens S Christiansen, Thomas W Donner, Emanuele Bosi, Bruce W Bode, Paolo Pozzilli. Diabetes Care 2014
Ronnie Aronson, Peter A Gottlieb, Jens S Christiansen, Thomas W Donner, Emanuele Bosi, Bruce W Bode, Paolo Pozzilli. Diabetes Care 2014
20
Evaluation of abatacept administered subcutaneously in adults with active rheumatoid arthritis: impact of withdrawal and reintroduction on immunogenicity, efficacy and safety (phase Iiib ALLOW study).
Jeffrey Kaine, Geoffrey Gladstein, Ingrid Strusberg, Manuel Robles, Ingrid Louw, Sheila Gujrathi, Ramesh Pappu, Ingrid Delaet, Miranda Pans, Charles Ludivico. Ann Rheum Dis 2012
Jeffrey Kaine, Geoffrey Gladstein, Ingrid Strusberg, Manuel Robles, Ingrid Louw, Sheila Gujrathi, Ramesh Pappu, Ingrid Delaet, Miranda Pans, Charles Ludivico. Ann Rheum Dis 2012
20
Efficacy and safety of abatacept, a T-cell modulator, in a randomised, double-blind, placebo-controlled, phase III study in psoriatic arthritis.
Philip J Mease, Alice B Gottlieb, Désirée van der Heijde, Oliver FitzGerald, Alyssa Johnsen, Marleen Nys, Subhashis Banerjee, Dafna D Gladman. Ann Rheum Dis 2017
Philip J Mease, Alice B Gottlieb, Désirée van der Heijde, Oliver FitzGerald, Alyssa Johnsen, Marleen Nys, Subhashis Banerjee, Dafna D Gladman. Ann Rheum Dis 2017
20
New Insights into Immunotherapy Strategies for Treating Autoimmune Diabetes.
Miriam Cabello-Olmo, Miriam Araña, Ilian Radichev, Paul Smith, Eduardo Huarte, Miguel Barajas. Int J Mol Sci 2019
Miriam Cabello-Olmo, Miriam Araña, Ilian Radichev, Paul Smith, Eduardo Huarte, Miguel Barajas. Int J Mol Sci 2019
33
The clinical impact of islet transplantation.
P Fiorina, A M J Shapiro, C Ricordi, A Secchi. Am J Transplant 2008
P Fiorina, A M J Shapiro, C Ricordi, A Secchi. Am J Transplant 2008
20
Teplizumab preserves C-peptide in recent-onset type 1 diabetes: two-year results from the randomized, placebo-controlled Protégé trial.
William Hagopian, Robert J Ferry, Nicole Sherry, David Carlin, Ezio Bonvini, Syd Johnson, Kathryn E Stein, Scott Koenig, Anastasia G Daifotis, Kevan C Herold,[...]. Diabetes 2013
William Hagopian, Robert J Ferry, Nicole Sherry, David Carlin, Ezio Bonvini, Syd Johnson, Kathryn E Stein, Scott Koenig, Anastasia G Daifotis, Kevan C Herold,[...]. Diabetes 2013
20
Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.